Tiziana Life Sciences Ltd (NASDAQ:TLSA) price on Thursday, July 03, fall -3.82% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.51.
A look at the stock’s price movement, the close in the last trading session was $1.57, moving within a range at $1.51 and $1.56. The beta value (5-Year monthly) was 0.107. Turning to its 52-week performance, $1.91 and $0.63 were the 52-week high and 52-week low respectively. Overall, TLSA moved 6.34% over the past month.
Tiziana Life Sciences Ltd’s market cap currently stands at around $168.30 million, with investors looking forward to this quarter’s earnings report slated for on 2020-Sep-30.
Turning to the stock’s technical picture we see that short term indicators suggest on average that TLSA is a 50% Buy. On the other hand, the stock is on average a 100% Buy as suggested by medium term indicators while long term indicators are putting the stock in 100% Buy category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend TLSA as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
TLSA’s current price about -2.27% and 2.89% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 48.99, while 7-day volatility ratio is 6.21% and 6.72% in the 30-day chart. Further, Tiziana Life Sciences Ltd (TLSA) has a beta value of -0.61.
If we refocus on Tiziana Life Sciences Ltd (NASDAQ:TLSA), historical trading data shows that trading volumes averaged 0.25 over the past 10 days and 350.11K over the past 3 months. The company’s latest data on shares outstanding shows there are 111.46 million shares.
The 43.37% of Tiziana Life Sciences Ltd’s shares are in the hands of company insiders while institutional holders own 2.70% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.6 million on 2025-06-13, giving us a short ratio of 1.95. The data shows that as of 2025-06-13 short interest in Tiziana Life Sciences Ltd (TLSA) stood at 77.0 of shares outstanding, with shares short falling to 0.91 million registered in 2025-05-15. Current price change has pushed the stock 70.51% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the TLSA stock continues to rise going into the next quarter.
